Amanta Healthcare is a leading Indian pharmaceutical company known for making high-quality medicines and healthcare products that are trusted in hospitals and clinics across the world. The company mainly produces sterile IV fluids, eye drops, antibiotics, injections, and other life-saving medicines that help doctors treat patients safely and effectively. With modern manufacturing plants and strict quality standards, Amanta Healthcare ensures its products meet global healthcare needs. The company also exports its medicines to many countries, making it an important player in the pharmaceutical and healthcare industry.
Amanta Healthcare Fundamental Analysis
| Metric | Value |
|---|---|
| Market Cap | ₹633 Cr |
| ROE | 7.46% |
| P/E Ratio (TTM) | 43.15 |
| EPS (TTM) | 3.78 |
| P/B Ratio | 2.88 |
| Dividend Yield | 0.00% |
| Industry P/E | 50.68 |
| Book Value | 56.71 |
| Debt to Equity | 1.11 |
| Face Value | 10 |
Amanta Healthcare Share Price Target 2026
Amanta Healthcare share price target for 2026 is expected to range from ₹120 to ₹180. Here are three key factors that could affect the company’s share price in 2026:
- Strong Demand for IV Fluids and Medical Solutions: Amanta makes essential fluid medicines like IV bottles and eye drops that hospitals use daily. Because doctors constantly need these liquid products to care for sick patients, sales remain steady throughout the year. Strong and continuous customer demand helps the company earn reliable income, which keeps stock investors happy and supports share prices.
- Advanced Blow-Fill-Seal Manufacturing Technology: The company uses high-tech machines that create, fill, and seal plastic medicine bottles without human hands touching them. This special process keeps liquid treatments completely clean and safe from germs. Having advanced factory equipment gives the company a big advantage over smaller rivals, attracting big health buyers and driving long-term value for company shareholders.
- Expansion of Factory Capacity with Fresh Funds: Using funds raised from its stock market launch, the business is building new production lines to make more liquid items. Adding modern equipment helps the factory produce millions of extra medicine bottles each year. Investors like seeing planned factory growth because bigger production capacity usually leads to higher sales numbers and larger profits over time.
Amanta Healthcare Share Price Target 2027
Amanta Healthcare share price target for 2027 is expected to range from ₹170 to ₹230. Here are three key factors that could affect the company’s share price in 2027:
- Growing Overseas Export Footprint: Amanta Healthcare sells its medical products to more than twenty countries across Africa, Latin America, and Europe. Selling goods globally means the business does not rely only on local Indian customers for revenue. Entering new international markets boosts total sales earnings and protects overall company income if domestic market conditions ever become difficult.
- Expanding Domestic Hospital Sales Network: Across India, the business partners with over three hundred distributors who deliver liquid products straight to local clinics and private nursing homes. This widespread supply system ensures hospitals can buy supplies whenever needed. Having a reliable nationwide selling network builds strong customer relationships, maintains steady order volume, and keeps overall company revenues growing smoothly.
- Diverse Portfolio of Over 45 Generic Medicines: The company creates more than forty-five different generic treatments, including breathing care fluids, wound cleaners, and rehydration drops. Offering a wide variety of medical items means the business does not depend on just one single popular product. A broad catalogue helps maintain steady income streams even if sales for one specific medicine drop suddenly.
Amanta Healthcare Share Price Target 2030
Amanta Healthcare share price target for 2030 is expected to range from ₹470 to ₹600. Here are three key factors that could affect the company’s share price in 2030:
- Strategic Partnerships with Big Pharma Brands: Besides selling under its own brand, Amanta makes custom liquid medicines for other large pharmaceutical companies. These commercial partnerships bring in large contract orders and keep manufacturing lines running at high speeds. Working alongside famous healthcare brands brings consistent payments, improves overall factory efficiency, and strengthens financial market trust among institutional stock buyers.
- Effective Repayment of Existing Loans: In past years, the business borrowed significant bank money to build its factories, which resulted in high yearly interest expenses. Using money from stock sales to pay off loan balances helps lower these debt costs. Lowering interest payments allows the company to keep more profit, making the business healthier and boosting equity share value.
- Strict Quality Standards and International Certifications: The company holds official global certificates showing its manufacturing facilities meet strict clean standards. Having international approvals proves that its liquid medicines are safe, pure, and dependable for medical use. Regulatory compliance opens doors to sell in strict foreign countries, giving the business a strong reputation that attracts long-term investors looking for stable growth.
Amanta Healthcare Share Price Target 2040
Amanta Healthcare share price target for 2040 is expected to range from ₹1200 to ₹1800. Here are three risks & challenges that could affect the company’s share price in 2040:
- Volatile Prices of Plastic Raw Materials: The main raw materials for making medicine containers are special plastic resins derived from petroleum. When crude oil prices rise globally, buying raw plastic becomes much more expensive for the factory. If the business cannot raise product prices quickly to cover higher material costs, profit margins shrink, which can worry stock market investors deeply.
- Fierce Rivalry from Established Pharmaceutical Giants: Amanta competes with many large Indian and global pharmaceutical manufacturers who make similar generic liquid items. Because many companies sell basic IV fluids, health buyers often choose products with the lowest price. Facing tough price wars limits how much profit the company can make, putting pressure on quarterly financial earnings and share performance.
- Strict Regulatory Rules and Approval Delays: Making liquid medicines requires following strict government safety rules and passing regular health inspections. If government health officers find factory issues or delay approving new product licenses, production can slow down or stop completely. Failing to meet regulatory standards can harm company reputation, delay sales growth, and cause sudden drops in market share prices.
Amanta Healthcare Share Price Target 2050
Amanta Healthcare share price target for 2050 is expected to range from ₹3500 to ₹4400. Here are three risks & challenges that could affect the company’s share price in 2050:
- Vulnerability to Foreign Exchange Rate Swings: Because the business exports medical supplies to over twenty foreign nations, it earns money in foreign currencies like dollars. Exchange rates between currencies change constantly due to global market conditions. If the Indian rupee becomes stronger, converting overseas revenue back into local currency yields less money, which can reduce total reported profits for shareholders.
- High Borrowing Costs and Outstanding Liabilities: Although the company is working to lower its debts, it still carries substantial bank loans from past expansion projects. Paying interest on large loans drains cash flow that could otherwise be used to grow the business. High financial debt creates extra risk during unexpected market downturns, making cautious investors hesitant to buy company shares.
- Operational Risks from Single Factory Concentration: Amanta conducts most of its manufacturing at its primary facility in Gujarat. Relying heavily on one main production location creates operational risks. Unexpected events like power cuts, equipment breakdowns, natural disasters, or local labor disputes could temporarily pause factory work. Halting factory output delays customer deliveries and hurts overall company revenue generation.
Amanta Healthcare Share Price Target 2026 To 2050
| Year | Target Price (₹) |
|---|---|
| 2026 | 120 to 180 |
| 2027 | 170 to 230 |
| 2028 | 240 to 320 |
| 2029 | 300 to 440 |
| 2030 | 470 to 600 |
| 2040 | 1200 to 1800 |
| 2050 | 3500 to 4400 |
Also Read: Mangal Electrical Share Price Target
Amanta Healthcare Shareholding Pattern
| Category | Holding |
|---|---|
| Promoters | 85.60% |
| Retail and Others | 14.40% |
Amanta Healthcare Key Competitors
Cipla, Sun Pharmaceutical Industries, Lupin, Dr. Reddy’s Laboratories, Zydus Lifesciences, Glenmark Pharmaceuticals, Aurobindo Pharma, Alembic Pharmaceuticals, Cadila Pharmaceuticals, and Intas Pharmaceuticals.
Disclaimer: All the information provided in this article is for educational and infomational purposes only. DateUpdateGo always advises seeking guidance from a certified financial advisor before making any investment-related decisions.
